• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect. COVID-19 Spike-host cell receptor GRP78 binding site prediction

tetano

Editor, Senior Moderator
J Infect. 2020 Mar 10. pii: S0163-4453(20)30107-9. doi: 10.1016/j.jinf.2020.02.026. [Epub ahead of print]
COVID-19 Spike-host cell receptor GRP78 binding site prediction.


Ibrahim IM[SUP]1[/SUP], Abdelmalek DH[SUP]1[/SUP], Elshahat ME[SUP]1[/SUP], Elfiky AA[SUP]2[/SUP].

Author information




Abstract

OBJECTIVES:

Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition.
METHODS:

In this study, the COVID-19 spike binding site to the cell-surface receptor (Glucose Regulated Protein 78 (GRP78)) is predicted using combined molecular modeling docking and structural bioinformatics. The COVID-19 spike protein is modeled using its counterpart, the SARS spike.
RESULTS:

Sequence and structural alignments show that four regions, in addition to its cyclic nature have sequence and physicochemical similarities to the cyclic Pep42. Protein-protein docking was performed to test the four regions of the spike that fit tightly in the GRP78 Substrate Binding Domain β (SBDβ). The docking pose revealed the involvement of the SBDβ of GRP78 and the receptor-binding domain of the coronavirus spike protein in recognition of the host cell receptor.
CONCLUSIONS:

We reveal that the binding is more favorable between regions III (C391-C525) and IV (C480-C488) of the spike protein model and GRP78. Region IV is the main driving force for GRP78 binding with the predicted binding affinity of -9.8 kcal/mol. These nine residues can be used to develop therapeutics specific against COVID-19.
Copyright ? 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.



KEYWORDS:

BiP; COVID-19 spike; GRP78; Pep42; protein-protein docking; structural bioinformatics


PMID:32169481DOI:10.1016/j.jinf.2020.02.026
 
Back
Top Bottom